Synchronization and integration of multiple hypertrophic pathways in the heart

Cardiovascular Research

Volumn 63, Issue 3, 2004, Pages 367-372

  Schlüter, Klaus Dieter ^a   Wollert, Kai C ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ; COCAINE; CYTOKINE; ENDOTHELIN; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; METHAMPHETAMINE; NEUROHORMONE; NITRIC OXIDE;

ADAPTATION; CELL GROWTH; EDITORIAL; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART SIZE; HEART STRESS; HORMONE ACTION; HUMAN; MECHANICAL STRESS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

ALDOSTERONE; CARDIOMEGALY; CYTOKINES; HUMANS; INTEGRINS; MYOCARDIUM; MYOCYTES, CARDIAC; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 3242785656     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.06.012     Document Type: Editorial

References (60)

1. Levy D., Garrison R.J., Savage D., Kannel W.B., Castelli W.P. Prognostic implication of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322:1990;1561-1566
2. Dorn G.W., Robbins J., Sugden P.H. Phenotyping hypertrophy. Eschew obfuscation. Circ. Res. 92:2003;1171-1175
3. Selvetella G., Hirsch E., Notte A., Tarone G., Lembo G. Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence. Cardiovasc. Res. 63:2004;373-380
4. Kaye D., Pimental D., Prasad S., et al. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J. Clin. Invest. 97:1996;281-291
5. 1A-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 364:2001;444-453
6. 1-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat. Am. J. Physiol. 279:2000;C495-C503
7. 2-adrenoceptor stimulation on adult ventricular cardiomyocytes. Mol. Cell. Biochem. 163/164:1996;211-216
8. Wada H., Zile M.R., Ivester C.T., Cooper G. IV, McDermott P.J. Comparative effects of contraction and angiotensin II on growth of adult feline cardiomyocytes in primary culture. J. Mol. Cell. Cardiol. 32:1996;947-960
9. Cullen J.P., Bell D., Kelso E.J., McDermott B.J. Use of A-192621 to provide evidence for involvement of endothelin ET(B)-receptors in endothelin-1-mediated cardiomyocytes hypertrophy. Eur. J. Pharmacol. 417:2001;157-168
10. Millar B.C., Schlüter K.-D., Zhou X.J., McDermott B.J., Piper H.M. Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes. Am. J. Physiol. 266:1994;C1271-C1277
11. Bell D., Schlüter K.-D., Zhou X.J., McDermott B.J., Piper H.M. Hypertrophic effects of calcitonin gene-related peptide (CGRP) and amylin on adult mammalian ventricular cardiomyocytes. J. Mol. Cell. Cardiol. 27:1995;2433-2443
12. Schlüter K.-D., Piper H.M. Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am. J. Physiol. 263:1992;H1739-H1746
13. Schlüter K.-D., Weber M., Piper H.M. Effects of PTHrP(1-07-111) and PTHrP(7-34) on adult cardiomyocytes. J. Mol. Cell. Cardiol. 29:1997;3057-3065
14. Huang C.Y., Hao L.Y., Buetow D.E. Insulin-like growth factor-induced hypertrophy of cultured adult rat cardiomyocytes is L-type calcium-channel- dependent. Mol. Cell. Biochem. 231:2002;51-59
15. Harder B.E., Schaub M.C., Eppenberger H.M., Eppenberger-Eberhardt M. Influence of fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-I) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular cardiomyocytes in culture. J. Mol. Cell. Cardiol. 28:1996;19-31
16. Yokoyama T., Nakano M., Bednarczyk J.L., McIntyre B.W., Entman M., Mann D.L. Tumor necrosis factor-alpha provokes a hypertrophy growth response in adult cardiac myocytes. Circulation. 95:1997;1247-1252
17. Wang F., Seta Y., Baumgarten G., Engel D.J., Sivasubramanian N., Mann D.L. Functional significance of hemodynamic overload-induced expression of leukaemia-inhibitory factor in the adult mammalian heart. Circulation. 103:2001;1296-1302
18. Henning R.J., Li Y. Cocaine produces cardiac hypertrophy by protein kinase C dependent mechanisms. J. Cardiovas. Pharmacol. Ther. 8:2003;149-160
19. Maeno Y., Iwasa M., Inoue H., Koyama H., Matoba R. Methamphetamine induces an increase in cell size and reorganization of myofibrils in cultured adult rat cardiomyocytes. Int. J. Leg. Med. 113:2000;201-207
20. Kent R.L., McDermott P.J. Passive load and angiotensin II evoke differential responses of gene expression and protein synthesis in cardiac myocytes. Circ. Res. 78:1996;829-838
21. Dzimiri N. Receptor crosstalk. Implication fort cardiovascular function, disease and therapy. Eur. J. Biochem. 269:2002;4713-4730
22. Ross R.S. Molecular and mechanical synergy: cross-talk between integrins and growth factor receptors. Cardiovasc. Res. 63:2004;381-390
23. Rapacciulo A., Esposito G., Caron K., Mao L., Thomas S.A., Rockman H.A. Important role of endogenous norepinpehrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J. Am. Coll. Cardiol. 38:2001;876-882
24. Barki-Harrington L., Perrino C., Rockman H.A. Network integration of the adrenergic system in cardiac hypertrophy. Cardiovasc. Res. 63:2004;391-402
25. Schlüter K.-D., Simm A., Schäfer M., Taimor G., Piper H.M. Early response kinase and PI 3-kinase activation in adult cardiomyocytes and their role in hypertrophy. Am. J. Physiol. 276:1999;H1655-H1663
26. Schlüter K.-D., Goldberg Y., Taimor G., Schäfer M., Piper H.M. Role of phosphatidylinositol 3-kinase activation in the hypertrophic growth of adult ventricular cardiomyocytes. Cardiovasc. Res. 40:1998;174-181
27. Proud C.G. Ras, PI 3-kinase and mTOR signalling in cardiac hypertrophy. Cardiovasc. Res. 63:2004;403-413
28. Schäfer M., Pönicke K., Heinroth-Hoffmann I., Brodde O.-E., Piper H.M., Schlüter K.-D. Beta-Adrenoceptor stimulation attenuates the hypertrophic effect of alpha-adrenoceptor stimulation in adult rat ventricular cardiomyocytes. J. Am. Coll. Cardiol. 37:2001;300-307
29. Barrett S., Honbo N., Karliner J.S. Alpha1-adrenoceptor mediated inhibition of cellular cAMP accumulation in neonatal rat ventricular myocytes. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;384-393
30. Pönicke K., Heinroth-Hoffmann I., Brodde O.-E. Differential effects of bucindolol and carvedilol on noradrenaline-induced hypertrophic response in ventricular cardiomyocytes of adult rats. J. Pharmacol. Exp. Ther. 301:2002;71-76
31. Pepe S., van den Brink O.W.V., Lakatta E.G., Xiao R.-P. β-Adrenergic receptor-opioid peptide receptor cross-talk: cardiovascular regulation and adaptation in health and disease. Cardiovasc. Res. 63:2004;414-422
32. Zhang Y., Bloem L.J., Yu L., et al. Protein kinase C βII activation induced angiotensin converting enzyme expression in neonatal rat cardiomyocytes. Cardiovasc. Res. 57:2003;139-146
33. Studer R., Reinecke H., Müller B., Holtz J., Just H., Drexler H. Increased angiotensin-I converting enzyme expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J. Clin. Invest. 94:1994;301-310
34. Hirsch A.T., Talsness C.E., Schunkert H., Paul M., Dzau V.J. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ. Res. 69:1991;475-482
35. Ozono R., Matsumoto T., Shingu T., et al. Expression and localization of angiotensin subtype receptor proteins in the hypertensive rat heart. Am. J. Physiol. 278:2000;R781-R789
36. Kaneko K., Susic D., Nunez E., Fröhlich E.D. Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat. J. Hypertens. 14:1996;645-653
37. 1A receptors. Am. J. Physiol. 274:1998;H868-H873
38. Harada K., Komuro I., Zou Y., et al. Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice. Circ. Res. 82:1998;779-785
39. Opie L.H., Sack M.N. Enhanced angiotensin II activity in heart failure: reevaluation of the counterregulatory hypothesis of receptors subtypes. Circ. Res. 88:2001;654-658
40. 1A-adrenergic receptor subtype mRNA and density in neonatal rat cardiac myocytes. Circ. Res. 81:1997;396-403
41. Schwartz D.D., Naff B.P. Activation of protein kinase C by angiotensin II decreases beta1-adrenergic receptor responsiveness in the rat heart. J. Cardiovas. Pharmacol. 29:1997;257-264
42. Asakura M., Kitakaze M., Takashima S., et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloprotease inhibitors as a new therapy. Nat. Med. 8:2002;35-40
43. Thomas W.G., Brandenburger Y., Autelitano D.J., Pham T., Qian H., Hannan R.D. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ. Res. 90:2002;135-142
44. Shah B.H., Catt K.J. A central role of EGF receptor transactivation in angiotensin II-induced cardiac hypertrophy. Trends Pharmacol. Sci. 24:2003;239-244
45. Pellieux C., Foletti A., Peduto G., et al. Dilated cardiomyopathy and impaired cardiac hypertrophy response to angiotensin II in mice lacking FGF-2. J. Clin. Invest. 108:2001;1843-1851
46. Ito H., Hirata Y., Hiroe M., et al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ. Res. 69:1991;209-215
47. Rosenkranz S. TGF-β and angiotensin networking in cardiac remodelling. Cardiovasc. Res. 63:2004;423-432
48. Sekiguchi K., Li X., Coker M.J., et al. Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure. Cardiovasc. Res. 63:2004;433-442
49. Rosenkranz A.C., Woods R.I., Dusting G.L., Ritchie R.H. Antihypertrophic actions of natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. Cardiovasc. Res. 57:2003;515-522
50. Luchner A., Schunkert H. Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system. Cardiovasc. Res. 63:2004;443-449
51. Rosenkranz A.C., Hood S.G., Woods R.L., Dusting G.J., Ritchie R.H. Acute antihypertrophic actions of bradykinin in the rat heart: importance of cyclic GMP. Hypertension. 40:2002;498-503
52. 2+ blockers prevent myocardial remodelling induced by chronic NO inhibition in rats. Hypertension. 41:2003;963-967
53. 2+ channels suppresses activation of calcineurin and development of cardiac hypertrophy in spontaneously hypertensive rats. Hypertens. Res. 25:2002;117-124
54. 2+-calcineurin-NFAT cascade in cardiac myocytes. Cardiovasc. Res. 63:2004;450-457
55. Kato J., Tsuruda T., Kitamura K., Eto T. Adrenomedullin: a possible autocrine or paracrine hormone in the cardiac ventricles. Hypertens. Res. 26:2003;S113-S119
56. Taimor G., Schlüter K.-D., Piper H.M. Hypertrophy-associated gene induction after β-adrenergic stimulation in adult cardiomyocytes. J. Mol. Cell. Cardiol. 33:2001;503-511
57. Autelitano D.J., Ridings R., Tang F. Adrenomedullin is a regulator of neonatal cardiomyocyte hypertrophy in vitro. Cardiovasc. Res. 51:2001;255-264
58. Niu P., Shindo T., Iwata H., et al. Accelerated cardiac hypertrophy and renal damage induced by angiotensin II in adrenomedullin knockout mice. Hypertens. Res. 26:2003;731-736
59. Nishikimi T., Yoshihara F., Horinaka S., et al. Chronic administration of adrenomedullin attenuates transition from left ventricular hypertrophy to heart failure in rats. Hypertension. 42:2003;1034-1041
60. Bell D., McDermott B.J. Contribution of de novo protein synthesis to the hypertrophic effect of IGF-1 but not of thyroid hormones in adult ventricular cardiomyocytes. Mol. Cell. Biochem. 206:2000;113-124